Semin Neurol 2002; 22(2): 133-142
DOI: 10.1055/s-2002-36536
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Infectious Myelopathies

Joseph R. Berger1,2 , Arman Sabet1
  • 1Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky
  • 2Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky
Further Information

Publication History

Publication Date:
13 January 2003 (online)

ABSTRACT

Although infectious myelopathies are rare, timely and accurate diagnosis is essential to improving outcome. There are a number of organisms that may cause infectious myelopathies, including human immunodeficiency virus (HIV), human T-cell lymphotropic virus type I (HTLV-I), herpesviruses, enteroviruses, Treponema pallidum, Mycobacterium tuberculosis, fungi, and parasites. Vacuolar myelopathy, the most common form of spinal cord disease in HIV-infected individuals, is underrecognized clinically. The failure to diagnose this condition is generally a consequence of the attribution of the lower extremity weakness and paresthesias to general debility and concomitant peripheral neuropathy. Tropical spastic paraparesis or HTLV-I-associated myelopathy involves the pyramidal tracts, chiefly at the thoracic level, and results in spastic lower extremity weakness and a spastic bladder. The herpesviruses (varicella-zoster, herpes simplex type 2, cytomegalovirus) and the enteroviruses cause myelitis. Prior to the development of antibiotics, syphilis was the most frequent infectious cause of spinal cord disease. In light of the broad spectrum of pathogens that may affect the spinal cord and the variegate fashion in which these disorders may present, the physician must always consider an infectious etiology in the differential diagnosis for the patient presenting with myelopathy. This review addresses the infectious myelopathies by microorganism.

REFERENCES

  • 1 Bhigjee A I, Madurai S, Bill P L. Spectrum of myelopathies in HIV seropositive South African patients.  Neurology . 2001;  57 348-351
  • 2 Petito C K, Navia B A, Cho E S, Jordan B D, George D C, Price R W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome.  N Engl J Med . 1985;  312 874-879
  • 3 Levy R M, Bredesen D E, Rosenblum M L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.  J Neurosurg . 1985;  62 475-495
  • 4 Helweg-Larsen S, Jakobsen J, Boesen F, Arlien-Soborg P. Neurological complications and concomitants of AIDS.  Acta Neurol Scand . 1986;  74 467-474
  • 5 de la Monte M S, Ho D D, Schooley R T, Hirsch M S, Richardson Jr P E. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection.  Neurology . 1987;  37 562-569
  • 6 Di Rocco A. Diseases of the spinal cord in human immunodeficiency virus infection.  Semin Neurol . 1999;  19 151-155
  • 7 Tagliati M, Di Rocco A, Danisi F, Simpson D M. The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy.  Neurology . 2000;  54 1477-1482
  • 8 Honig L, Vogel H, Horoupian D. Chronic myelopathy as a presenting symptom in HIV infection [abstract].  Neurology . 1989;  39(suppl 1) 419
  • 9 Goldstick L, Mandybur T I, Bode R. Spinal cord degeneration in AIDS.  Neurology . 1985;  35 10310-10316
  • 10 Shepherd E J, Brettle R P, Liberski P P. Spinal cord pathology and viral burden in homosexuals and drug users with AIDS.  Neuropathol Appl Neurobiol . 1999;  25 2-10
  • 11 Kamin S S, Petito C K. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients.  Hum Pathol . 1991;  22 816-824
  • 12 Singh B M, Levine S, Yarrish R L, Hyland M J, Jeanty D, Wormser G P. Spinal cord syndromes in the acquired immune deficiency syndrome.  Acta Neurol Scand . 1986;  73 590-598
  • 13 Di Rocco A, Simpson D M. AIDS-associated vacuolar myelopathy.  AIDS Patient Care STDS . 1998;  12 457-461
  • 14 Tan S V, Guiloff R J. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS.  J Neurol Neurosurg Psychiatry . 1998;  65 23-28
  • 15 Dickson D W, Belman A L, Kim T S, Horoupian D S, Rubinstein A. Spinal cord pathology in pediatric acquired immunodeficiency syndrome.  Neurology . 1989;  39 227-235
  • 16 Geraci A, Di Rocco A, Liu M. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid.  Neurology . 2000;  55 440-442
  • 17 Denning D W, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus.  Br Med J (Clin Res Ed) . 1987;  294 143-144
  • 18 Narciso P, Galgani S, Del Grosso B. Acute disseminated encephalomyelitis as manifestation of primary HIV infection.  Neurology . 2001;  57 1493-1496
  • 19 Staudinger R, Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy.  Neurology . 2000;  54 267-268
  • 20 Williams A E, Fang C T, Slamon D J. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.  Science . 1988;  240 643-646
  • 21 Robert-Guroff M, Weiss S, Giron J. Prevalence of antibodies to HTLV-1, -II, and -III in intravenous drug abusers from an AIDS endemic region.  JAMA . 1986;  255 3133-3137
  • 22 Khabbaz R F, Darrow W W, Hartley T M. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States.  JAMA . 1990;  263 60-64
  • 23 Sheremata W A, Berger J R, Harrington Jr J W, Ayyar D R, Stafford M, DeFreitas E. Human T lymphotropic virus type I-associated myelopathy: a report of 10 patients born in the United States.  Arch Neurol . 1992;  49 1113-1118
  • 24 Gotuzzo E, Arango C, de Queiroz-Campos A, Isturiz R E. Human T-cell lymphotropic virus-I in Latin America.  Infect Dis Clin North Am . 2000;  14 211-239
  • 25 Gessain A, Barin F, Vernant J C. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.  Lancet . 1985;  2 407-410
  • 26 Osame M, Usuku K, Izumo S. HTLV-I associated myelopathy, a new clinical entity.  Lancet . 1986;  1 1031-1032
  • 27 Vernant J C, Maurs L, Gessain A. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases.  Ann Neurol . 1987;  21 123-130
  • 28 Akizuki S, Nakazato O, Higuchi Y. Necropsy findings in HTLV-I associated myelopathy.  Lancet . 1987;  1 156-157
  • 29 Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy.  Neuropathology . 2000;  20(suppl) S65-S68
  • 30 Castillo L C, Gracia F, Roman G C, Levine P, Reeves W C, Kaplan J. Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/ HTLV-II): report of 3 cases from Panama.  Acta Neurol Scand . 2000;  101 405-412
  • 31 Zehender G, De Maddalena C, Osio M. High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1-associated predominantly sensory polyneuropathy.  J Infect Dis . 1995;  172 1595-1598
  • 32 Mitsui Y, Kusunoki S, Hiruma S. Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human T-cell leukemia virus I infection.  Muscle Nerve . 1999;  22 1461-1465
  • 33 Smith C R, Dickson D, Samkoff L. Recurrent encephalopathy and seizures in a US native with HTLV-I-associated myelopathy/tropical spastic paraparesis: a clinicopathologic study.  Neurology . 1992;  42 658-661
  • 34 Nagai M, Yamano Y, Brennan M B, Mora C A, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.  Ann Neurol . 2001;  50 807-812
  • 35 Berger J R. PML in AIDS.  Neurology . 1992;  42 1845-1846
  • 36 Lehky T J, Flerlage N, Katz D. Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles.  Ann Neurol . 1996;  40 714-723
  • 37 Puccioni-Sohler M, Rios M, Carvalho S M. Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index.  Neurology . 2001;  57 725-727
  • 38 Nakagawa M, Nakahara K, Maruyama Y. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.  J Neurovirol . 1996;  2 345-355
  • 39 Stambos V, Brussen K A, Turnbull A, Thorley B, Kennett M. Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000.  Commun Dis Intell . 2001;  25 54-58
  • 40 Rose F, Brett E, Burton J. Zoster encephalomyelitis.  Arch Neurol . 1964;  11 155
  • 41 Baik J S, Kim W C, Heo J H, Zheng H Y. Recurrent herpes zoster myelitis.  J Korean Med Sci . 1997;  12 360-363
  • 42 Kleinschmidt-DeMasters B K, Gilden D H. The expanding spectrum of herpesvirus infections of the nervous system.  Brain Pathol . 2001;  11 440-451
  • 43 de Silva M S, Mark A S, Gilden D H. Zoster myelitis: improvement with antiviral therapy in two cases.  Neurology . 1996;  47 929-931
  • 44 Caplan L R, Kleeman F J, Berg S. Urinary retention probably secondary to herpes genitalis.  N Engl J Med . 1977;  297 920-921
  • 45 Klastersky J, Capperl R, Snoeck J M. Ascending myelitis in association with herpes simplex virus.  N Engl J Med . 1982;  287 182
  • 46 Grose C, Feorino P M. Epstein-Barr virus and transverse myelitis.  Lancet . 1973;  1 892
  • 47 Silverstein A. Epstein-Barr virus infections of the nervous system. In: Vinken P, Bruyn G, eds. Infections of the Nervous System Amsterdam: North Holland 1978: 185-192
  • 48 Tyler K L, Gross R A, Cascino G D. Unusual viral causes of transverse myelitis: hepatitis A virus and cytomegalovirus.  Neurology . 1986;  36 855-858
  • 49 Paine R, Byers R. Transverse myelopathy in childhood.  Am J Child . 1953;  85 151
  • 50 Altrocchi P. Acute transverse myelopathy.  Arch Neurol . 1963;  9 111
  • 51 Lipton H L, Teasdall R D. Acute transverse myelopathy in adults: a follow-up study.  Arch Neurol . 1973;  28 252-257
  • 52 Ropper A H, Poskanzer D C. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms.  Ann Neurol . 1978;  4 51-59
  • 53 Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations.  Neurology . 1981;  31 966-971
  • 54 Berger J. Syphilis of the spinal cord. In: Davidoff RA, ed. Handbook of the Spinal Cord New York: Marcel Dekker 1987: 491-538
  • 55 Berger J R, Moskowitz L, Fischl M, Kelley R E. Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome.  South Med J . 1987;  80 683-686
  • 56 Fisher M, Poser C M. Syphilitic meningomyelitis: a case report.  Arch Neurol . 1977;  34 785
  • 57 Gribble L D. Syphilitic spinal pachymeningitis.  S Afr Med J . 1972;  46 1326-1328
  • 58 Centers for Disease Control. Recommended treatment schedules, 1976.  Ann Intern Med . 1976;  85 94
  • 59 Berger J. Neurosyphilis. In: Johnson R, ed. Current Therapies in Neurology Philadelphia: BC Dekker 1990: 143-148
  • 60 Griffiths D L. Tuberculosis of the spine: a review.  Adv Tuberc Res . 1980;  20 92-110
  • 61 Nussbaum E S, Rockswold G L, Bergman T A, Erickson D L, Seljeskog E L. Spinal tuberculosis: a diagnostic and management challenge.  J Neurosurg . 1995;  83 243-247
  • 62 Kim S W, Kim R C, Choi B H, Gordon S K. Non-traumatic ischaemic myelopathy: a review of 25 cases.  Paraplegia . 1988;  26 262-272
  • 63 Kaynar M Y, Kocer N, Gencosmanoglu B E, Hanci M. Syringomyelia: as a late complication of tuberculous meningitis.  Acta Neurochir . 2000;  142 935-938
  • 64 White V L, Al-Shahi R, Gamble E, Brown P, Davison A G. Transverse myelopathy and radiculomyelopathy associated with pulmonary atypical Mycobacterium infections.  Thorax . 2001;  56 158-160
  • 65 Moon M S, Ha K Y, Sun D H, Moon J L, Moon Y W, Chung J H. Pott's paraplegia: 67 cases.  Clin Orthop . 1996;  323 122-128
  • 66 Vidyasagar C, Murthy H K. Spinal tuberculosis with neurological deficits.  Natl Med J India . 1996;  9 25-27
  • 67 Dutton J, Alexander G. Intramedullary spinal abscess.  J Neurol Neurosurg Psychiatry . 1954;  17 303
  • 68 Miller H, Stanton J, Gibbons J. Parainfectious encephalomyelitis and related syndromes: a critical review of the neurologic complications of certain specific fevers.  J Med . 1956;  25 427
  • 69 Kincaid J, Dyken M. Myelitis and myelopathy. In: Baker A, Baker L, eds. Clinical Neurology New York: Harper & Row 1982: 1-31
  • 70 Pickeritt R, Milder J. Transverse myelitis associated with cat-scratch disease in an adult.  JAMA . 1981;  246 2840-2841
  • 71 Reik L, Steere A C, Bartenhagen N H, Shope R E, Malawista S E. Neurologic abnormalities of Lyme disease.  Medicine (Baltimore) . 1979;  58 281-294
  • 72 Gumbo T, Hakim J G, Mielke J, Siwji S, Just-Nubling G, Ismail A. Cryptococcus myelitis: atypical presentation of a common infection.  Clin Infect Dis . 2001;  32 1235-1236
  • 73 Koh S, Ross L A, Gilles F H, Nelson Jr D M, Mitchell W G. Myelopathy resulting from invasive aspergillosis.  Pediatr Neurol . 1998;  19 135-138
  • 74 Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients.  Neurosurg Rev . 2000;  23 175-205
  • 75 Kaufman D M, Kaplan J G, Litman N. Infectious agents in spinal epidural abscesses.  Neurology . 1980;  30 844-850
  • 76 Baker A, Ojemann R, Swartz M, Richardson Jr P E. Spinal epidural abscess.  N Engl J Med . 1975;  293 463-468